Lindaksa - it's a drug , the active substance which is sibutramine hydrochloride monohydrate and sibutramine. Sibutramine is a centrally acting drug aneroksigenny and affects the center of food saturation. Effect of the drug is that it causes a feeling of saturation due to the oppression of serotonin reuptake. Lindaksa used as an adjunctive therapy for a comprehensive program to reduce excess weight .
Sibutramine, which is part of Lindaksy impeded flow of serotonin in the body and ensures a constant high level. The pleasure that a person gets from food related, including a production of serotonin, which is also called "hormone of happiness." An interesting fact is that sibutramine was originally developed as a product of depression. His positive influence on the psycho-emotional state of a person forced developers to think about the possibility of using sibutramine for the production of drugs for obesity.
Manufacturer Lindaksy - Czech pharmaceutical company "Zentiva" in the instructions for preparation focuses on the fact that the drug should be administered to patients with large body mass (BMI ≥ 27-30), and only to those who, within three months did not help the standard non-pharmacological scheme weight loss. That is, if the patient failed within three months to reduce body weight for at least 5%, using diet and exercise, the appointment Lindaksy can be justified. Such a serious approach to the advisability of the appointment and use of the drug due to the fact that Lindaksa has on the human body is quite a significant impact and has a large number of contraindications.
These contraindications are the presence of mental illness, with mental disorder and taking medication for their treatment, coronary heart disease, congenital heart disease or heart failure, the presence of organic causes of obesity in a patient, the presence of bulimia nervosa or a history, tachycardia or arrhythmia, cerebral vascular lesion, which include stroke, severe renal dysfunction and liver, etc. In addition, absolutely can not take the medication during pregnancy or breast -feeding , as well as the existing drug, drug or alcohol addiction in history.
Lindaksa drug is available in two dosages - 10 mg and 15 mg, depending on the dose contained sibutramine. Start taking the drug should be a dosage of 10 mg. If the reduction of excess weight is less than 2 kg for 4 weeks under normal tolerability, may be appointed Lindaksa 15 mg. In the event, and further therapy is not producing tangible results, the reception Lindaksy deemed inappropriate.
When the available indicators of positive and lasting reduction of excess weight, duration of drug treatment can range from three months to a year. Lindaksu longer take it is not recommended, since no data on the safety of such long-term treatment.
Lindaksa allows a person to feel satiated, even after receiving a small portion of food that gradually reduces the volume of the stomach. Thus, changing lifestyles and dietary habits of man, there is a reduction in body weight. In this case, there is no state of irritation, which occurs during dieting. But do not forget that the failure of this new style of life after discontinuation of the drug leads to repeated weight gain. Comprehensive approach that includes changes in eating behavior, exercise regularly and taking the drug Lindaksa will help permanently preserve the results achieved and after discontinuation of the drug.
Among the side effects in the first two weeks of taking the drug observed phenomena such as high blood pressure , tachycardia, sweating, insomnia, dry mouth. Much less can be nausea, headache, pain , dizziness and changes in taste sensations .
Do not forget that Lindaksa as any drug on the basis of sibutramine, is a serious medicine and may be assigned only to endocrinologists.
